Moroxydine
ANTIINFECTIVES FOR SYSTEMIC USE
Also known as: moroxidine, moroxidine HCl, moroxidine hydrochloride, vironil, virumin
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Moroxydine is a drug catalogued in DrugCentral. Recorded indications include Influenza.
- Indications: Influenza.
- ATC code: J05AX01 (Other antivirals).
- Molecular formula: C6H13N5O; molecular weight 171.20 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Influenza
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
J05AX01 | ANTIINFECTIVES FOR SYSTEMIC USE › ANTIVIRALS FOR SYSTEMIC USE › DIRECT ACTING ANTIVIRALS › Other antivirals |
Chemical structure
| Molecular formula | C6H13N5O |
|---|---|
| Molecular weight | 171.20 g/mol |
| CAS number | 3731-59-7 |
| InChIKey | KJHOZAZQWVKILO-UHFFFAOYSA-N |
| PubChem CID | 71655 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Moroxydine used for?
DrugCentral lists the following indications for Moroxydine: Influenza.
What is the chemical formula of Moroxydine?
Moroxydine has the molecular formula C6H13N5O and a molecular weight of 171.20 g/mol.
Browse: all drugs starting with M · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1844 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1490434 — compound record and bioactivity
- PubChem CID 71655 — chemical identifiers
- DrugBank DB13597 — drug record
- FDA UNII O611591WAH — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.